PROM1 and precursor B-cell acute lymphoblastic leukemia: Furthermore, the screening of 28 B-ALL patients showed substantial expression (≥20%; SFI ≥ 1.5) of CD133 on leukemic cells in 50% (14 of 28) with SFI levels up to 114.9 in the analyzed patient samples (Figure 1B,C).